137 related articles for article (PubMed ID: 8520057)
1. Anti-melanoma monoclonal antibody 225.28S immunoscintigraphy in metastatic melanoma.
Böni R; Huch Böni RA; Steinert H; Dummer R; Burg G; von Schulthess GK
Dermatology; 1995; 191(2):119-23. PubMed ID: 8520057
[TBL] [Abstract][Full Text] [Related]
2. [Radioimmunoscintigraphy with a 99mTc-labeled F(ab')2 fragment of a monoclonal antibody (HMW-MAA 225.28S) in 71 patients with malignant melanoma].
Rentsch M; Cerny T; Geiger L; Gerber H; Brunner KW; Rösler H; Nachbur B
Schweiz Med Wochenschr; 1989 Oct; 119(40):1382-5. PubMed ID: 2552577
[TBL] [Abstract][Full Text] [Related]
3. Imaging with 131I-labeled monoclonal antibodies to a high-molecular-weight melanoma-associated antigen in patients with melanoma: efficacy of whole immunoglobulin and its F(ab')2 fragments.
Buraggi GL; Callegaro L; Mariani G; Turrin A; Cascinelli N; Attili A; Bombardieri E; Terno G; Plassio G; Dovis M
Cancer Res; 1985 Jul; 45(7):3378-87. PubMed ID: 4005860
[TBL] [Abstract][Full Text] [Related]
4. Immunoscintigraphy with 99mTc labelled F(ab')2 fragments of an anti melanoma monoclonal antibody (225.28S) in patients with metastatic malignant melanoma.
Cerny T; Owens SE; Mackenzie SA; Nuttall PM; Gosh AK; Smith DB; Thatcher N
Eur J Nucl Med; 1987; 13(3):130-3. PubMed ID: 3622556
[TBL] [Abstract][Full Text] [Related]
5. Radioimmunodetection of melanoma: preliminary results of a prospective study.
Buraggi G; Turrin A; Cascinelli N; Attili A; Gasparini M; Callegaro L; Ferrone S; Seregni E; Bombardieri E; Belli F
Int J Biol Markers; 1986; 1(1):47-54. PubMed ID: 2826619
[TBL] [Abstract][Full Text] [Related]
6. Radioimmunoscintigraphy of ocular melanoma with 99mTc labelled cutaneous melanoma antibody fragments.
Bomanji J; Hungerford JL; Granowska M; Britton KE
Br J Ophthalmol; 1987 Sep; 71(9):651-8. PubMed ID: 2822079
[TBL] [Abstract][Full Text] [Related]
7. Multicenter study of immunoscintigraphy with radiolabeled monoclonal antibodies in patients with melanoma.
Siccardi AG; Buraggi GL; Callegaro L; Mariani G; Natali PG; Abbati A; Bestagno M; Caputo V; Mansi L; Masi R
Cancer Res; 1986 Sep; 46(9):4817-22. PubMed ID: 3731128
[TBL] [Abstract][Full Text] [Related]
8. Role of technetium 99m-labeled monoclonal antibody in the management of melanoma patients.
Blend MJ; Ronan SG; Salk DJ; Gupta TK
J Clin Oncol; 1992 Aug; 10(8):1330-7. PubMed ID: 1634923
[TBL] [Abstract][Full Text] [Related]
9. [Immunoscintigraphy with 99mTc marked melanoma antibody in patients with malignant melanoma].
Rentsch M; Cerny T; Richner J; Brunner KW; Rösler H; Nachbur B
Helv Chir Acta; 1989 Jun; 56(1-2):11-3. PubMed ID: 2777587
[TBL] [Abstract][Full Text] [Related]
10. [Immunoscintigraphy with a technetium 99m-labeled monoclonal antibody in patients with melanoma].
Dudczak R; Kletter K; Bailer H; Kokoschka E; Pohl-Markl H
Wien Klin Wochenschr; 1987 Apr; 99(7):232-9. PubMed ID: 3590802
[TBL] [Abstract][Full Text] [Related]
11. Radioimmunoscintigraphy in patients with early stage cutaneous malignant melanoma.
Blend MJ; Hyun H; Patel B; Sullivan K; Salk D
J Nucl Med; 1996 Feb; 37(2):252-7. PubMed ID: 8667055
[TBL] [Abstract][Full Text] [Related]
12. Immunoscintigraphy with anti-225.28S for ocular melanoma--a comparison with histology and immunohistochemistry.
Bräutigam P; Loeffler KU; Krause T; Högerle S; Simon J; Moser E
Nuklearmedizin; 1997 Mar; 36(2):42-6. PubMed ID: 9090646
[TBL] [Abstract][Full Text] [Related]
13. Clinical utility of external immunoscintigraphy with the IMMU-4 technetium-99m Fab' antibody fragment in patients undergoing surgery for carcinoma of the colon and rectum: results of a pivotal, phase III trial. The Immunomedics Study Group.
Moffat FL; Pinsky CM; Hammershaimb L; Petrelli NJ; Patt YZ; Whaley FS; Goldenberg DM
J Clin Oncol; 1996 Aug; 14(8):2295-305. PubMed ID: 8708720
[TBL] [Abstract][Full Text] [Related]
14. Anti-melanoma antibodies bind preferentially to diploid metastases in immunoscintigraphy.
Pyrhönen S; Liewendahl K; Muhonen T; Laasonen A; Asko-Seljavaara S; Lindroth L; Franssila KO; Virkkunen P; Brownell AL
Nucl Med Commun; 1990 Sep; 11(9):597-605. PubMed ID: 2234695
[TBL] [Abstract][Full Text] [Related]
15. Radioimmunoscintigraphy with 99mTc-225.28S-F(ab')2 in cutaneous and ocular melanomas: cases of particular clinical interest.
Salzillo F; Mele M; Lombardo T; Delle Noci N; Minervini C; D'Addabbo A
J Nucl Biol Med (1991); 1993 Dec; 37(4):191-7. PubMed ID: 8172959
[TBL] [Abstract][Full Text] [Related]
16. Immunoscintigraphy for ocular melanoma: a reliable diagnostic technique?
Loeffler KU; Bräutigam P; Simon JC; Althauser SR; Wuttig C; Witschel H
Graefes Arch Clin Exp Ophthalmol; 1996 Feb; 234(2):100-4. PubMed ID: 8720679
[TBL] [Abstract][Full Text] [Related]
17. Current role of immunoscintigraphy in malignant melanoma follow-up. A study of 114 patients.
Ribuffo D; Cavalieri L; De Vita F; Massa R; Prosperi D; Tuccimei M; Scuderi N
J Exp Clin Cancer Res; 2001 Mar; 20(1):11-5. PubMed ID: 11370816
[TBL] [Abstract][Full Text] [Related]
18. Immunoscintigraphy in intraocular malignant melanoma.
Scheidhauer K; Markl A; Leinsinger G; Moser E; Scheiffarth OF; Riedel KG; Schaal TS; Stefani FH; Schumacher U
Nucl Med Commun; 1988 Sep; 9(9):669-78. PubMed ID: 3263596
[TBL] [Abstract][Full Text] [Related]
19. Diagnosing suspected acute nonclassic appendicitis with sulesomab, a radiolabeled antigranulocyte antibody imaging agent.
Passalaqua AM; Klein RL; Wegener WA; Crawford JA; Crow JP; Andrews DA; Goldenberg DM
J Pediatr Surg; 2004 Sep; 39(9):1338-44. PubMed ID: 15359387
[TBL] [Abstract][Full Text] [Related]
20. Improved immunoscintigraphy by subcutaneous injection of 99mTc or 111In labelled F(ab')2 fragments of an anti-melanoma monoclonal antibody.
Paganelli G; Riva P; Moscatelli G; Stacchiotti A; Agostini M; Landi G; Tison V; Pancea P; Siccardi AG
Int J Rad Appl Instrum B; 1986; 13(4):423-8. PubMed ID: 3793497
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]